<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/7a05f52a-05f1-4409-8985-8c1f0b9c8f16/5FFB7D59-CCBB-4338-90B6-295220B778B4/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=505405" href="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=505405" style="font-size: 11px;">www.investors.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=505405"><P>The record penalty assessed to <SPAN class="company">Pfizer</SPAN> (<A rel="StockSymbol.axd?symbol=PFE" href="javascript:navigateToPage('~/StockResearch/Quote.aspx?Symbol=PFE');" class="stockRoll">PFE</A>) last week for unlawful prescription drug promotions grabbed plenty of headlines, but it had a muted reaction on Wall Street.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=505405"><P>Analysts and investors already knew that Pfizer, the world's biggest drugmaker, would face a steep fine for some of its marketing practices. The company itself had reserved money for that specific purpose many months ago.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=505405"><P>So while the $2.3 billion civil and criminal penalty dished out by the Justice Department made noise in the media — not least because it was the largest such fine ever administered — it had little impact on Pfizer's stock price.</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/5FFB7D59-CCBB-4338-90B6-295220B778B4/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!